The Tele-Rehab MV Cluster Stepped-Wedge Randomized Clinical Trial (Tele-Rehab MV)

February 20, 2026 updated by: Hospital Israelita Albert Einstein

Evaluation of an Integrated Multicomponent Telemedicine-Based Intervention on Health-Related Quality of Life in Adults With Acute Respiratory Failure Requiring Mechanical Ventilation (Tele-Rehab MV Trial)

To evaluate, through a randomized clinical trial in groups/clusters (stepped wedge), the impact of specific bundles for disability prevention and early rehabilitation, focused on 3 domains (ICU, ward and post-discharge), on health-related quality of life and other long- and short-term outcomes, 90 days after hospital discharge, in critically ill patients affected by hypoxemic acute respiratory failure.

Study Overview

Detailed Description

Acute respiratory failure requiring invasive mechanical ventilation is associated with significant mortality rates. Furthermore, survivors often develop new physical, mental, and cognitive disabilities, as well as worsening clinical conditions, which can significantly impair their health-related quality of life. COVID-19 remains a notable cause of acute respiratory failure and long-term disabilities,6 with the added potential to cause persistent symptoms regardless of the infection's initial severity. Although the incidence of SARS-CoV-2-related respiratory failure has declined with the widespread adoption of vaccination, it persists as an endemic cause of pneumonia, particularly among patients with significant comorbidities, and is often part of the differential diagnosis in severe cases of acute hypoxemic respiratory failure. While bundles of interventions including analgesia optimization, sedation minimization, early mobilization, and delirium prevention, as well as screening for individuals at risk of new disabilities for early rehabilitation have been recommended to prevent disabilities in critical care patients, no large randomized clinical trial has yet demonstrated a significant impact on long-term health-related quality of life. Additionally, the burden of disability following critical illness is often associated with patients' inability to attend clinic-based follow-up, and telemedicine may serve as a tool to reduce healthcare inequalities. Accordingly, the primary objective of this cluster stepped-wedge randomized clinical trial is to assess the impact of a multicomponent telemedicine-based intervention on the health-related quality of life of patients with acute hypoxemic respiratory failure requiring invasive mechanical ventilation, evaluated 90 days after hospital discharge.

Study Type

Interventional

Enrollment (Actual)

1916

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rio de Janeiro, Brazil
        • Hospital Municipal Ronaldo Gazolla
    • Alagoas
      • Arapiraca, Alagoas, Brazil
        • Hospital de Emergência Dr. Daniel Houly
    • Amazonas
      • Manaus, Amazonas, Brazil
        • Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
    • Ceará
      • Fortaleza, Ceará, Brazil
        • Hospital de Messejana Dr. Carlos Alberto Studart Gomes (HM)
      • Sobral, Ceará, Brazil
        • Hospital Regional Norte - HRN
    • Estado de Bahia
      • Salvador, Estado de Bahia, Brazil
        • Hospital Municipal de Salvador
      • Vitória da Conquista, Estado de Bahia, Brazil
        • Hospital Geral de Vitória da Conquista
    • Federal District
      • Brasília, Federal District, Brazil
        • Hospital Regional de Samambaia
    • Goiás
      • Aparecida de Goiânia, Goiás, Brazil
        • Hospital Municipal Aparecida de Goiania - HMAP
      • Goiânia, Goiás, Brazil
        • Hospital Estadual de Doenças Tropicais Dr. Anuar Auad
    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brazil
        • Santa Casa de Misericórdia de Belo Horizonte
    • Paraná
      • Londrina, Paraná, Brazil
        • Hospital Universitário - Universidade Estadual de Londrina
    • Paraíba
      • Campina Grande, Paraíba, Brazil
        • Hospital Municipal Pedro I
    • Pernambuco
      • Recife, Pernambuco, Brazil
        • Instituto de Medicina Integral "Prof. Fernando Figueira" - IMIP
    • Piauí
      • Parnaíba, Piauí, Brazil
        • Hospital Estadual Dirceu Arcoverde
    • Rio Grande do Sul
      • Venâncio Aires, Rio Grande do Sul, Brazil
        • Hospital São Sebastião Martir
    • Rondônia
      • Porto Velho, Rondônia, Brazil
        • Centro De Pesquisa Em Medicina Tropical - CEPEM
    • Roraima
      • Boa Vista, Roraima, Brazil
        • Hospital Geral de Roraima - HGR
    • Santa Catarina
      • Lages, Santa Catarina, Brazil
        • Hospital Geral e Maternidade Tereza Ramos
    • Tocantins
      • Augustinópolis, Tocantins, Brazil
        • Hospital Regional de Augustinópolis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Aged ≥18 years
  2. Admission to the ICU with hypoxemic acute respiratory failure in whom SARS-CoV-2 infection is part of the differential diagnosis will be enrolled. This does not imply that COVID-19 is the primary suspected cause, but rather that it is considered at least a possible (though not necessarily probable) diagnosis at the time of ICU admission.
  3. Need for invasive mechanical ventilation.

Exclusion Criteria:

  1. Severe underlying disease with a life expectancy of less than 3 months;
  2. Absence of a responsible family member for cases of patients with communication difficulties (aphasia, severe cognitive impairment, non-native speakers of Portuguese);
  3. Absence of telephone contact;
  4. Participants already included in the study;
  5. Unavailability to carry out telephone follow-ups.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard of Care
Standard of care provided by participating hospitals
Standard of Care provided by enrolling hospitals
Experimental: Rehabilitation
An implementation bundle of measures to improve outcomes in intensive care unit, hospital, and after hospital discharge, including rehabilitation at home performed through telemedicine.
Standard of Care provided by enrolling hospitals
The study intervention is an evidence-based, multicomponent program focused on disability prevention and rehabilitation strategies, implemented during the patient's ICU stay, continued through ward admission, and extending up to two months post-hospital discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 90 days after hospital discharge
Health-related quality of life assessed by the Brazilian version of the 5-dimension, 3-level EuroQol scale (EQ-5D-3L)
90 days after hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rehospitalization
Time Frame: 30 days after hospital discharge
New hospitalization
30 days after hospital discharge
Return to work
Time Frame: 90 days after hospital discharge
Return to work or usual activities (work, study)
90 days after hospital discharge
Mortality
Time Frame: From study enrollment (ICU admission) to 90 days after hospital discharge
All cause mortality
From study enrollment (ICU admission) to 90 days after hospital discharge
Days alive and free of hospital
Time Frame: From study enrollment (ICU admission) to 90 days after hospital discharge
Days alive and free of hospital (not hospitalized)
From study enrollment (ICU admission) to 90 days after hospital discharge
Anxiety and Depression
Time Frame: 90 days after hospital discharge
Anxiety and depression measured according to Hospital Anxiety and Depression Scale
90 days after hospital discharge
New disability in instrumental activities of daily living
Time Frame: 90 days after hospital discharge
Incidence of new disabilities for instrumental activities of daily living assessed by the Lawton & Brody scale
90 days after hospital discharge
Physical dependence
Time Frame: 90 days after hospital discharge
Prevalence of moderate, severe, or total physical disability assessed by the modified Barthel Index
90 days after hospital discharge
Clinical Status
Time Frame: 90 days after hospital discharge
Ordinal scale from using World Health Organization
90 days after hospital discharge
Cognitive impairment
Time Frame: 90 days after hospital discharge
Prevalence of cognitive impairment assessed by the Telephone Interview for Cognitive Status
90 days after hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Adriano Pereira, Hospital Israelita Albert Einstein

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2024

Primary Completion (Actual)

September 5, 2025

Study Completion (Actual)

September 5, 2025

Study Registration Dates

First Submitted

March 26, 2024

First Submitted That Met QC Criteria

March 26, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 20, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data belongs to Brazilian Ministry of Health. May be shared upon agreement

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Failure

Clinical Trials on Standard of Care

Subscribe